These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 16793573

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
    Kinirons P, McCarthy M, Doherty CP, Delanty N.
    Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Identifying baseline characteristics of placebo responders versus nonresponders in randomized double-blind trials of refractory partial-onset seizures.
    Niklson I, Edrich P, Verdru P.
    Epileptic Disord; 2006 Mar; 8(1):37-44. PubMed ID: 16567324
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
    Stefan H, Wang-Tilz Y, Pauli E, Dennhöfer S, Genow A, Kerling F, Lorber B, Fraunberger B, Halboni P, Koebnick C, Gefeller O, Tilz C.
    Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615
    [Abstract] [Full Text] [Related]

  • 28. Levetiracetam: new preparation. For some patients with refractory partial epilepsy.
    Prescrire Int; 2003 Apr; 12(64):53-4. PubMed ID: 12674114
    [Abstract] [Full Text] [Related]

  • 29. Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome.
    Wisniewski CS.
    Ann Pharmacother; 2010 Apr; 44(4):658-67. PubMed ID: 20233912
    [Abstract] [Full Text] [Related]

  • 30. Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy.
    Tanaka S, Tanaka T.
    Epileptic Disord; 2013 Jun; 15(2):132-41. PubMed ID: 23774199
    [Abstract] [Full Text] [Related]

  • 31. Levetiracetam: preliminary efficacy in generalized seizures.
    Kasteleijn-Nolst Trenité DG, Hirsch E.
    Epileptic Disord; 2003 May; 5 Suppl 1():S39-44. PubMed ID: 12915340
    [Abstract] [Full Text] [Related]

  • 32. Zonisamide as adjunctive therapy for refractory partial seizures.
    Brodie MJ.
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S11-6. PubMed ID: 16316744
    [Abstract] [Full Text] [Related]

  • 33. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
    Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Gauer LJ, Lu Z, N159 Study Group.
    Neurology; 2006 Jun 13; 66(11):1654-60. PubMed ID: 16641323
    [Abstract] [Full Text] [Related]

  • 34. Dose-response population analysis of levetiracetam add-on treatment in refractory epileptic patients with partial onset seizures.
    Snoeck E, Stockis A.
    Epilepsy Res; 2007 Mar 13; 73(3):284-91. PubMed ID: 17196793
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
    Baulac M, Leppik IE.
    Epilepsy Res; 2007 Jul 13; 75(2-3):75-83. PubMed ID: 17553670
    [Abstract] [Full Text] [Related]

  • 36. Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeks.
    Piña-Garza JE, Schiemann-Delgado J, Yang H, Duncan B, Hadac J, Hunter SJ.
    Clin Ther; 2010 Oct 13; 32(11):1935-50. PubMed ID: 21095488
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
    Xiao Z, Li JM, Wang XF, Xiao F, Xi ZQ, Lv Y, Sun HB.
    Eur Neurol; 2009 Oct 13; 61(4):233-9. PubMed ID: 19176965
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients.
    Heo K, Lee BI, Yi SD, Huh K, Kim JM, Lee SA, Shin DJ, Song HK, Lee SK, Kim JY, Lu S, Dubois C, Tonner F.
    Seizure; 2007 Jul 13; 16(5):402-9. PubMed ID: 17369059
    [Abstract] [Full Text] [Related]

  • 39. Levetiracetam for people with mental retardation and refractory epilepsy.
    Kelly K, Stephen LJ, Brodie MJ.
    Epilepsy Behav; 2004 Dec 13; 5(6):878-83. PubMed ID: 15582836
    [Abstract] [Full Text] [Related]

  • 40. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS, Kothare SV, Valencia I, Melvin JJ, Legido A.
    Pediatr Neurol; 2007 Apr 13; 36(4):227-30. PubMed ID: 17437904
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.